Literature DB >> 19955323

Effector functions of camelid heavy-chain antibodies in immunity to West Nile virus.

L P Daley1, M A Kutzler, B W Bennett, M C Smith, A L Glaser, J A Appleton.   

Abstract

Three classes of IgG have been described for camelids. IgG1 has a conventional four-chain structure, while IgG2 and IgG3 do not incorporate light chains. The structures and antigen-binding affinities of the so-called heavy-chain classes have been studied in detail; however, their regulation and effector functions are largely undefined. The aim of this study was to examine the participation of conventional and heavy-chain IgG antibodies in the camelid immune defense directed against West Nile virus (WNV). We found that natural infection or vaccination with killed WNV induced IgG1 and IgG3. Vaccination also induced IgG1 and IgG3; IgG2 was produced during the anamnestic response to vaccination. When purified IgGs were tested in plaque-reduction neutralization titer (PRNT) tests, IgG3 demonstrated PRNT activities comparable to those of conventional IgG1. In contrast, IgG2 demonstrated only suboptimal activity at the highest concentrations tested. Flow cytometric analysis revealed that macrophages bound IgG1, IgG2, and IgG3. Furthermore, subneutralizing concentrations of all three isotypes enhanced WNV infection of cultured macrophages. Our results document distinctions in regulation and function between camelid heavy-chain isotypes. The reduced size and distinct structure of IgG3 did not negatively impact its capacity to neutralize virus. In contrast, IgG2 appeared to be less efficient in neutralization. This information advances our understanding of these unusual antibodies in ways that can be applied in the development of effective vaccines for camelids.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19955323      PMCID: PMC2815534          DOI: 10.1128/CVI.00421-09

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


  34 in total

Review 1.  Recognition of antigens by single-domain antibody fragments: the superfluous luxury of paired domains.

Authors:  S Muyldermans; C Cambillau; L Wyns
Journal:  Trends Biochem Sci       Date:  2001-04       Impact factor: 13.807

2.  The structure of the llama heavy chain constant genes reveals a mechanism for heavy-chain antibody formation.

Authors:  B P Woolven; L G Frenken; P van der Logt; P J Nicholls
Journal:  Immunogenetics       Date:  1999-10       Impact factor: 2.846

3.  Antigen specificity and high affinity binding provided by one single loop of a camel single-domain antibody.

Authors:  A Desmyter; K Decanniere; S Muyldermans; L Wyns
Journal:  J Biol Chem       Date:  2001-05-07       Impact factor: 5.157

4.  Identification of neutralizing epitopes within structural domain III of the West Nile virus envelope protein.

Authors:  David W C Beasley; Alan D T Barrett
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

5.  Induction of immune responses and molecular cloning of the heavy chain antibody repertoire of Lama glama.

Authors:  R van der Linden; B de Geus; W Stok; W Bos; D van Wassenaar; T Verrips; L Frenken
Journal:  J Immunol Methods       Date:  2000-06-23       Impact factor: 2.303

6.  Replication of West Nile virus in equine peripheral blood mononuclear cells.

Authors:  David Garcia-Tapia; Christie M Loiacono; Steven B Kleiboeker
Journal:  Vet Immunol Immunopathol       Date:  2005-11-28       Impact factor: 2.046

7.  Canonical antigen-binding loop structures in immunoglobulins: more structures, more canonical classes?

Authors:  K Decanniere; S Muyldermans; L Wyns
Journal:  J Mol Biol       Date:  2000-06-30       Impact factor: 5.469

8.  Flow cytometric analysis of an immunodeficiency disorder affecting juvenile llamas.

Authors:  W C Davis; L R Heirman; M J Hamilton; S M Parish; G M Barrington; A Loftis; M Rogers
Journal:  Vet Immunol Immunopathol       Date:  2000-04-19       Impact factor: 2.046

9.  Development of resistance to passive therapy with a potently neutralizing humanized monoclonal antibody against West Nile virus.

Authors:  Shuliu Zhang; Matthew R Vogt; Theodore Oliphant; Michael Engle; Evgeniy I Bovshik; Michael S Diamond; David W C Beasley
Journal:  J Infect Dis       Date:  2009-07-15       Impact factor: 5.226

10.  Engineering a camelid antibody fragment that binds to the active site of human lysozyme and inhibits its conversion into amyloid fibrils.

Authors:  Pak-Ho Chan; Els Pardon; Linda Menzer; Erwin De Genst; Janet R Kumita; John Christodoulou; Dirk Saerens; Alain Brans; Fabrice Bouillenne; David B Archer; Carol V Robinson; Serge Muyldermans; André Matagne; Christina Redfield; Lode Wyns; Christopher M Dobson; Mireille Dumoulin
Journal:  Biochemistry       Date:  2008-09-25       Impact factor: 3.162

View more
  8 in total

1.  Contributions of conventional and heavy-chain IgG to immunity in fetal, neonatal, and adult alpacas.

Authors:  L P Daley-Bauer; S R Purdy; M C Smith; L F Gagliardo; W C Davis; J A Appleton
Journal:  Clin Vaccine Immunol       Date:  2010-10-06

2.  Analysis of heavy-chain antibody responses and resistance to Parelaphostrongylus tenuis in experimentally infected alpacas.

Authors:  S R Purdy; L F Gagliardo; S Lefman; P J S Hamel; S Ku; T Mainini; G Hoyt; K Justus; L P Daley-Bauer; M S Duffy; J A Appleton
Journal:  Clin Vaccine Immunol       Date:  2012-05-16

3.  Polyclonal alpaca antibodies protect against hantavirus pulmonary syndrome in a lethal Syrian hamster model.

Authors:  Patrycja Sroga; Angela Sloan; Bryce M Warner; Kevin Tierney; Jocelyne Lew; Guodong Liu; Michael Chan; Yvon Deschambault; Derek R Stein; Geoff Soule; Logan Banadyga; Darryl Falzarano; David Safronetz
Journal:  Sci Rep       Date:  2021-08-31       Impact factor: 4.996

4.  Ultra-sensitive Serial Profiling of SARS-CoV-2 Antigens and Antibodies in Plasma to Understand Disease Progression in COVID-19 Patients with Severe Disease.

Authors:  Alana F Ogata; Adam M Maley; Connie Wu; Tal Gilboa; Maia Norman; Roey Lazarovits; Chih-Ping Mao; Gail Newton; Matthew Chang; Katrina Nguyen; Maliwan Kamkaew; Quan Zhu; Travis E Gibson; Edward T Ryan; Richelle C Charles; Wayne A Marasco; David R Walt
Journal:  Clin Chem       Date:  2020-09-08       Impact factor: 8.327

5.  Peste des petits ruminants infection in domestic ruminants in Sudan.

Authors:  K S Intisar; Y H Ali; M A Haj; M A T Sahar; M M Shaza; A M Baraa; O M Ishag; Y M Nouri; K M Taha; E M Nada; A M Ahmed; A I Khalafalla; G Libeau; A Diallo
Journal:  Trop Anim Health Prod       Date:  2017-03-20       Impact factor: 1.893

Review 6.  Alternative reagents to antibodies in imaging applications.

Authors:  R Bedford; C Tiede; R Hughes; A Curd; M J McPherson; Michelle Peckham; Darren C Tomlinson
Journal:  Biophys Rev       Date:  2017-07-27

7.  Coming together at the hinges: Therapeutic prospects of IgG3.

Authors:  Thach H Chu; Edward F Patz; Margaret E Ackerman
Journal:  MAbs       Date:  2021 Jan-Dec       Impact factor: 5.857

8.  Blocking of Histamine Release and IgE Binding to FcεRI on Human Basophils by Antibodies Produced in Camels.

Authors:  Al Qaoud Khaled; Yousef Sana; Rawashdeh Abdulrahman; Khalil Raida; Abdel Hafez Sami
Journal:  Allergy Asthma Immunol Res       Date:  2015-06-25       Impact factor: 5.764

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.